Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring

Biochemical Pharmacology

Volumn 88, Issue 4, 2014, Pages 573-583

  Stroh, Matthew ^a,b   Swerdlow, Russell H ^b   Zhu, Hao ^a,b,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Alzheimer's disease; Diabetes; Iron; Mitochondria; Neurodegeneration

Indexed keywords

4 AMINOBUTYRIC ACID; AMYLOID BETA PROTEIN; EXENDIN 4; FERRITIN; FRATAXIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; GLUCOSE TRANSPORTER; GLUTAMATE DECARBOXYLASE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; INSULIN; NERVE CELL ADHESION MOLECULE; NEUROTRANSMITTER RECEPTOR; NOTCH RECEPTOR; SODIUM CHANNEL; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; TRANSFERRIN;

ACTION POTENTIAL; ALZHEIMER DISEASE; CELL MIGRATION; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE CELL; FRIEDREICH ATAXIA; GENE EXPRESSION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IRON METABOLISM; IRON METABOLISM DISORDER; IRON OVERLOAD; METABOLIC DISORDER; MONOGENIC DISORDER; NERVE CELL; NERVE DEGENERATION; NEUROFILAMENT; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; SECRETORY GRANULE;

ALZHEIMER'S DISEASE; DIABETES; IRON; MITOCHONDRIA; NEURODEGENERATION;

ANIMALS; DIABETES MELLITUS; DISEASE SUSCEPTIBILITY; GENETIC VARIATION; HUMANS; IRON; MICE; MITOCHONDRIA; NEURODEGENERATIVE DISEASES;

EID: 84897954360     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.11.022     Document Type: Review

References (195)

1. R.H. Swerdlow Brain aging, Alzheimer's disease, and mitochondria Biochim Biophys Acta 1812 12 2011 1630 1639
2. R.H. Swerdlow The neurodegenerative mitochondriopathies J Alzheimers Dis 17 4 2009 737 751
3. B.B. Lowell, and G.I. Shulman Mitochondrial dysfunction and type 2 diabetes Science 307 5708 2005 384 387 (Pubitemid 40139974)
4. Q. Liu, L. Sun, Y. Tan, G. Wang, X. Lin, and L. Cai Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications Curr Med Chem 16 1 2009 113 129
5. A. Van Campenhout, C. Van Campenhout, A.R. Lagrou, G. Moorkens, C. De Block, and B. Manuel-y-Keenoy Iron-binding antioxidant capacity is impaired in diabetes mellitus Free Radic Biol Med 40 10 2006 1749 1755
6. L. Zecca, M.B. Youdim, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 11 2004 863 873 (Pubitemid 39482155)
7. L. Batista-Nascimento, C. Pimentel, R.A. Menezes, and C. Rodrigues-Pousada Iron and neurodegeneration: from cellular homeostasis to disease Oxid Med Cell Longev 2012 2012 128647
8. K. Wakabayashi Cellular pathology of neurodegenerative disorders Rinsho Shinkeigaku 53 8 2013 609 617
9. J. Sharma Alzheimer's disease: an update Nurs J India 103 6 2012 245 248
10. M.G. Spillantini, and M. Goedert Tau pathology and neurodegeneration Lancet Neurol 12 6 2013 609 622
11. P. Tieh, and D. Dreimane Type 2 diabetes mellitus in children and adolescents Indian J Pediatr 2013 10.1007/s12098-013-1193-6 [Epub ahead of print]
12. L.K. Scott Presence of type 2 diabetes risk factors in children Pediatr Nurs 39 4 2013 190 196 180
13. J. Wu, S.D. Nie, and S. Wang Tau pathology in diabetes mellitus Pharmazie 68 8 2013 649 652
14. T. Yamashima Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis' - a perspective review Prog Neurobiol 105 2013 1 23
15. A. Tiiman, P. Palumaa, and V. Tougu The missing link in the amyloid cascade of Alzheimer's disease - metal ions Neurochem Int 62 4 2013 367 378
16. H.S. Grover, and S. Luthra Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease J Indian Soc Periodontol 17 3 2013 292 301
17. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011
18. M. Ristow Neurodegenerative disorders associated with diabetes mellitus J Mol Med (Berl) 82 8 2004 510 529 (Pubitemid 39149861)
19. J. Janson, T. Laedtke, J.E. Parisi, P. O'Brien, R.C. Petersen, and P.C. Butler Increased risk of type 2 diabetes in Alzheimer disease Diabetes 53 2 2004 474 481 (Pubitemid 38174565)
20. Z. Arvanitakis, R.S. Wilson, J.L. Bienias, D.A. Evans, and D.A. Bennett Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function Arch Neurol 61 5 2004 661 666 (Pubitemid 38637681)
21. P. Langerhans Beitrage zur mikroscopischen anatomie der bauchspeichel druse (Inaugural-dissertation) 1869
22. M.E. Arntfield, and D. van der Kooy Beta-cell evolution: how the pancreas borrowed from the brain Bioessays 33 8 2011 582 587
23. A.G. Pearse, and J.M. Polak Neural crest origin of the endocrine polypeptide (APUD) cells of the gastrointestinal tract and pancreas Gut 12 10 1971 783 788
24. T. Fujita, S. Kobayashi, and R. Yui Paraneuron concept and its current implications Adv Biochem Psychopharmacol 25 1980 321 325
25. P. Maechler, and C.B. Wollheim Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis Nature 402 6762 1999 685 689 (Pubitemid 129516341)
26. A. Reetz, M. Solimena, M. Matteoli, F. Folli, K. Takei, and P. De Camilli GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion EMBO J 10 5 1991 1275 1284 (Pubitemid 21905590)
27. T. Gonoi, N. Mizuno, N. Inagaki, H. Kuromi, Y. Seino, and J. Miyazaki et al. Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6 J Biol Chem 269 25 1994 16989 16992 (Pubitemid 24204010)
28. J.C. Henquin, and H.P. Meissner Significance of ionic fluxes and changes in membrane-potential for stimulus-secretion coupling in pancreatic B-cells Experientia 40 10 1984 1043 1052 (Pubitemid 15147090)
29. X.J. Yang, L.M. Kow, T. Funabashi, and C.V. Mobbs Hypothalamic glucose sensor - similarities to and differences from pancreatic beta-cell mechanisms Diabetes 48 9 1999 1763 1772 (Pubitemid 29415195)
30. E. Sunami, H. Kanazawa, H. Hashizume, M. Takeda, K. Hatakeyama, and T. Ushiki Morphological characteristics of Schwann cells in the islets of Langerhans of the murine pancreas Arch Histol Cytol 64 2 2001 191 201 (Pubitemid 32578441)
31. M. Hebrok, and L.F. Reichardt Brain meets pancreas: netrin, an axon guidance molecule, controls epithelial cell migration Trends Cell Biol 14 4 2004 153 155 (Pubitemid 38447113)
32. O.K. Langley, M.C. Aletseeufrecht, N.J. Grant, and M. Gratzl Expression of the neural cell-adhesion molecule Ncam in endocrine-cells J Histochem Cytochem 37 6 1989 781 791 (Pubitemid 19156460)
33. J. van Arensbergen, J. Garcia-Hurtado, I. Moran, M.A. Maestro, X.B. Xu, and M. Van de Casteele et al. Derepression of polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program Genome Res 20 6 2010 722 732
34. L.H. Philipson, A. Kusnetsov, T. Larson, Y.J. Zeng, and G. Westermark Human, rodent, and canine pancreatic beta-cells express a sodium-channel alpha-1-subunit related to a fetal brain isoform Diabetes 42 9 1993 1372 1377 (Pubitemid 23259858)
35. F. Atouf, P. Czernichow, and R. Scharfmann Expression of neuronal traits in pancreatic beta cells - implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer J Biol Chem 272 3 1997 1929 1934 (Pubitemid 27043287)
36. S.A. Cruz, Y.C. Tseng, H. Kaiya, and P.P. Hwang Ghrelin affects carbohydrate-glycogen metabolism via insulin inhibition and glucagon stimulation in the zebrafish (Danio rerio) brain Comp Biochem Physiol A Mol Integr Physiol 156 2 2010 190 200
37. S.U. Devaskar, S.J. Giddings, P.A. Rajakumar, L.R. Carnaghi, R.K. Menon, and D.S. Zahm Insulin gene-expression and insulin synthesis in mammalian neuronal cells J Biol Chem 269 11 1994 8445 8454 (Pubitemid 24200266)
38. C. Leloup, M. Arluison, N. Lepetit, N. Cartier, P. Marfaingjallat, and P. Ferre et al. Glucose-transporter 2 (Glut-2) - expression in specific brain nuclei Brain Res 638 1-2 1994 221 226 (Pubitemid 24063308)
39. S. Thor, J. Ericson, T. Brannstrom, and T. Edlund The homeodomain LIM protein Isl-1 is expressed in subsets of neurons and endocrine-cells in the adult-rat Neuron 7 6 1991 881 889
40. J. Jensen Gene regulatory factors in pancreatic development Dev Dyn 229 1 2004 176 200 (Pubitemid 38036833)
41. C. Schuurmans, and F. Guillemot Molecular mechanisms underlying cell fate specification in the developing telencephalon Curr Opin Neurobiol 12 1 2002 26 34 (Pubitemid 34175271)
42. M. Muller, N. Jabs, D.E. Lorke, B. Fritzsch, and M. Sander Nkx6.1 controls migration and axon pathfinding of cranial branchio-motoneurons Development 130 23 2003 5815 5826 (Pubitemid 37540854)
43. F. Vult von Steyern, V. Martinov, I. Rabben, A. Nja, O. de Lapeyriere, and T. Lomo The homeodomain transcription factors Islet 1 and HB9 are expressed in adult alpha and gamma motoneurons identified by selective retrograde tracing Eur J Neurosci 11 6 1999 2093 2102 (Pubitemid 29240574)
44. J. Song, Y. Xu, X. Hu, B. Choi, and Q. Tong Brain expression of Cre recombinase driven by pancreas-specific promoters Genesis 48 11 2010 628 634
45. A.C. Thomas-Reetz, and P. De Camilli A role for synaptic vesicles in non-neuronal cells: clues from pancreatic beta cells and from chromaffin cells FASEB J 8 2 1994 209 216
46. P. Rorsman, P.O. Berggren, K. Bokvist, H. Ericson, H. Mohler, and C.G. Ostenson et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels Nature 341 6239 1989 233 236 (Pubitemid 19231723)
47. R. Rodriguez-Diaz, R. Dando, M.C. Jacques-Silva, A. Fachado, J. Molina, and M.H. Abdulreda et al. Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans Nat Med 17 7 2011 888 892
48. V. Campuzano, L. Montermini, M.D. Molto, L. Pianese, M. Cossee, and F. Cavalcanti et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 271 5254 1996 1423 1427 (Pubitemid 26089479)
49. H. Koutnikova, V. Campuzano, F. Foury, P. Dolle, O. Cazzalini, and M. Koenig Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin Nat Genet 16 4 1997 345 351 (Pubitemid 27323298)
50. A. Durr, M. Cossee, Y. Agid, V. Campuzano, C. Mignard, and C. Penet et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia N Engl J Med 335 16 1996 1169 1175 (Pubitemid 26339770)
51. E. Kim, M. Napierala, and S.Y.R. Dent Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia Nucleic Acids Res 39 19 2011 8366 8377
52. S. Polling, A.F. Hill, and D.M. Hatters Polyglutamine aggregation in Huntington and related diseases Adv Exp Med Biol 769 2012 125 140
53. A.L. Robertson, and S.P. Bottomley Molecular pathways to polyglutamine aggregation Adv Exp Med Biol 769 2012 115 124
54. P.O. Bauer, and N. Nukina The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies J Neurochem 110 6 2009 1737 1765
55. S. Adinolfi, C. Iannuzzi, F. Prischi, C. Pastore, S. Iametti, and S.R. Martin et al. Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS Nat Struct Mol Biol 16 4 2009 390 396
56. S. Schmucker, A. Martelli, F. Colin, A. Page, M. Wattenhofer-Donze, and L. Reutenauer et al. Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex PLoS ONE 6 1 2011
57. M. Perdomini, A. Hick, H. Puccio, and M.A. Pook Animal and cellular models of Friedreich ataxia J Neurochem 126 2013 65 79
58. M. Ristow, H. Mulder, D. Pomplun, T.J. Schulz, K. Muller-Schmehl, and A. Krause et al. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass J Clin Invest 112 4 2003 527 534 (Pubitemid 38056337)
59. H. Puccio, D. Simon, M. Cossee, P. Criqui-Filipe, F. Tiziano, and J. Melki et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits Nat Genet 27 2 2001 181 186 (Pubitemid 32157445)
60. J.C. Florez, J. Hirschhorn, and D. Altshuler The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits Annu Rev Genomics Hum Genet 4 2003 257 291 (Pubitemid 37392926)
61. M. Hutton, and J. Hardy The presenilins and Alzheimer's disease Hum Mol Genet 6 10 1997 1639 1646 (Pubitemid 27401606)
62. C. Haass, C.A. Lemere, A. Capell, M. Citron, P. Seubert, and D. Schenk et al. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway Nat Med 1 12 1995 1291 1296
63. J.M. Shulman, P.L. De Jager, and M.B. Feany Parkinson's disease: genetics and pathogenesis Annu Rev Pathol 6 2011 193 222
64. W. Wang, Y. Guo, M. Xu, H.H. Huang, L. Novikova, and K. Larade et al. Development of diabetes in lean Ncb5or-null mice is associated with manifestations of endoplasmic reticulum and oxidative stress in beta cells Biochim Biophys Acta 1812 11 2011 1532 1541
65. G. Andersen, L. Wegner, C.S. Rose, J. Xie, H. Zhu, and K. Larade et al. Variation in NCB5OR: studies of relationships to type 2 diabetes, maturity-onset diabetes of the young, and gestational diabetes mellitus Diabetes 53 11 2004 2992 2997 (Pubitemid 39425926)
66. J.T. Rogers, A.I. Bush, H.H. Cho, D.H. Smith, A.M. Thomson, and A.L. Friedlich et al. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease Biochem Soc Trans 36 Pt 6 2008 1282 1287
67. J.A. Duce, A. Tsatsanis, M.A. Cater, S.A. James, E. Robb, and K. Wikhe et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 142 6 2010 857 867
68. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, and M. Mallory et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress Am J Pathol 157 2 2000 401 410 (Pubitemid 30627559)
69. D. Protter, C. Lang, and A.A. Cooper alphaSynuclein and mitochondrial dysfunction: a pathogenic partnership in Parkinson's disease? Parkinsons Dis 2012 2012 829207
70. J.X. Xie, H. Zhu, K. Larade, A. Ladoux, A. Seguritan, and M. Chu et al. Absence of a reductase, NCB50R, causes insulin-deficient diabetes Proc Natl Acad Sci USA 101 29 2004 10750 10755 (Pubitemid 38955814)
71. J.M. van den Ouweland, H.H. Lemkes, R.C. Trembath, R. Ross, G. Velho, and D. Cohen et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu(UUR)) gene Diabetes 43 6 1994 746 751
72. H.Y. Wang, P. Maechler, P.A. Antinozzi, K.A. Hagenfeldt, and C.B. Wollheim Hepatocyte nuclear factor 4 alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion J Biol Chem 275 46 2000 35953 35959
73. H.Y. Wang, P.A. Antinozzi, K.A. Hagenfeldt, P. Maechler, and C.B. Wollheim Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction EMBO J 19 16 2000 4257 4264 (Pubitemid 30623736)
74. M.A. Brehm, A.C. Powers, L.D. Shultz, and D.L. Greiner Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice Cold Spring Harb Perspect Med 2 5 2012
75. K. Larade, Z.G. Jiang, Y.Z. Zhang, W.F. Wang, S. Bonner-Weir, and H. Zhu et al. Loss of Ncb5or results in impaired fatty acid desaturation, lipoatrophy, and diabetes J Biol Chem 283 43 2008 29285 29291
76. F.S. Kalman, B. Lizak, S.K. Nagy, T. Meszaros, V. Zambo, and J. Mandl et al. Natural mutations lead to enhanced proteasomal degradation of human Ncb5or, a novel flavoheme reductase Biochimie 95 7 2013 1403 1410
77. H. Zhu, W.F. Wang, H.P. Wang, M. Xu, L. E, and R.H. Swerdlow Impaired iron metabolism in monogenic Ncb5or diabetes Diabetes 62 2013 556 587 [abstract]
78. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population - prevalence estimates using the 2000 census Arch Neurol 60 8 2003 1119 1122 (Pubitemid 36975801)
79. C.C. Liu, T. Kanekiyo, H. Xu, and G. Bu Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Nat Rev Neurol 9 2 2013 106 118
80. J.M. Castellano, J. Kim, F.R. Stewart, H. Jiang, R.B. DeMattos, and B.W. Patterson et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance Sci Transl Med 3 89 2011 89ra57
81. E.M. Reiman, K.W. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, and D. Osborne et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc Natl Acad Sci USA 101 1 2004 284 289 (Pubitemid 38084242)
82. J. Valla, R. Yaari, A.B. Wolf, Y. Kusne, T.G. Beach, and A.E. Roher et al. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon 4 allele, the major late-onset Alzheimer's susceptibility gene J Alzheimers Dis 22 1 2010 307 313
83. S. Minoshima, N.L. Foster, and D.E. Kuhl Posterior cingulate cortex in Alzheimer's disease Lancet 344 8926 1994 895 (Pubitemid 24290409)
84. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, and S. Minoshima et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E N Engl J Med 334 12 1996 752 758 (Pubitemid 26089356)
85. E.M. Reiman, R.J. Caselli, K. Chen, G.E. Alexander, D. Bandy, and J. Frost Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease Proc Natl Acad Sci USA 98 6 2001 3334 3339 (Pubitemid 32220846)
86. G.E. Alexander, K. Chen, P. Pietrini, S.I. Rapoport, and E.M. Reiman Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies Am J Psychiatry 159 5 2002 738 745 (Pubitemid 34465046)
87. J. Valla, J.D. Berndt, and F. Gonzalez-Lima Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration J Neurosci 21 13 2001 4923 4930 (Pubitemid 32565651)
88. W.S. Liang, E.M. Reiman, J. Valla, T. Dunckley, T.G. Beach, and A. Grover et al. Alzheimer's disease is associated with reduced expression of energy in posterior cingulate metabolism genes neurons Proc Natl Acad Sci USA 105 11 2008 4441 4446 (Pubitemid 351754399)
89. C.S. Bloss, D.C. Delis, D.P. Salmon, and M.W. Bondi Decreased cognition in children with risk factors for Alzheimer's disease Biol Psychiatry 64 10 2008 904 906
90. A. Makris, A. Piperopoulos, and I. Karmaniolou Multiple sclerosis: basic knowledge and new insights in perioperative management J Anesth 2013 10.1007/s00540-013-1697-2 [Epub ahead of print]
91. P. Ponka Hereditary causes of disturbed iron homeostasis in the central nervous system Ann N Y Acad Sci 1012 2004 267 281 (Pubitemid 38453531)
92. A.G. Vlassenko, M.A. Mintun, C.J. Xiong, Y.I. Sheline, A.M. Goate, and T.L.S. Benzinger et al. Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11 C]Pittsburgh compound B data Ann Neurol 70 5 2011 857 861
93. S.W. Pimplikar Reassessing the amyloid cascade hypothesis of Alzheimer's disease Int J Biochem Cell Biol 41 6 2009 1261 1268
94. P.A. Trimmer, R.H. Swerdlow, J.K. Parks, P. Keeney, J.P. Bennett Jr., and S.W. Miller et al. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines Exp Neurol 162 1 2000 37 50 (Pubitemid 30170099)
95. A.C. Belin, B.F. Bjork, M. Westerlund, D. Galter, O. Sydow, and C. Lind et al. Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease Neurosci Lett 420 3 2007 257 262 (Pubitemid 46856016)
96. R.H. Swerdlow, and S.M. Khan A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease Med Hypotheses 63 1 2004 8 20 (Pubitemid 38887104)
97. R.H. Swerdlow, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis: an update Exp Neurol 218 2 2009 308 315
98. R.H. Swerdlow, J.M. Burns, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis J Alzheimers Dis 20 Suppl. 2 2010 S265 S279
99. R.H. Swerdlow, J.M. Burns, and S.M. Khan The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives Biochim Biophys Acta 2013 10.1016/j.bbadis.2013.09.010 pii: S0925-4439(13)00289-5 [Epub ahead of print]
100. E.K. Perry, R.H. Perry, B.E. Tomlinson, G. Blessed, and P.H. Gibson Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase Neurosci Lett 18 1 1980 105 110 (Pubitemid 10122792)
101. S. Sorbi, E.D. Bird, and J.P. Blass Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain Ann Neurol 13 1 1983 72 78 (Pubitemid 13224203)
102. G.E. Gibson, K.F. Sheu, J.P. Blass, A. Baker, K.C. Carlson, and B. Harding et al. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease Arch Neurol 45 8 1988 836 840
103. E. Steen, B.M. Terry, E.J. Rivera, J.L. Cannon, T.R. Neely, and R. Tavares et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7 1 2005 63 80 (Pubitemid 40387185)
104. K. Talbot, H.Y. Wang, H. Kazi, L.Y. Han, K.P. Bakshi, and A. Stucky et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 122 4 2012 1316 1338
105. W.D. Parker Jr., C.M. Filley, and J.K. Parks Cytochrome oxidase deficiency in Alzheimer's disease Neurology 40 8 1990 1302 1303 (Pubitemid 20244999)
106. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, and L.J. Chang et al. Brain cytochrome oxidase in Alzheimer's disease J Neurochem 59 2 1992 776 779
107. E.M. Mutisya, A.C. Bowling, and M.F. Beal Cortical cytochrome-oxidase activity is reduced in Alzheimers-disease J Neurochem 63 6 1994 2179 2184 (Pubitemid 24369993)
108. L. Gasparini, M. Racchi, L. Benussi, D. Curti, G. Binetti, and A. Bianchetti et al. Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells Neurosci Lett 231 2 1997 113 117 (Pubitemid 27386502)
109. D. Gabuzda, J. Busciglio, L.B. Chen, P. Matsudaira, and B.A. Yankner Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative J Biol Chem 269 18 1994 13623 13628 (Pubitemid 24206141)
110. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, and P.A. Trimmer et al. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways Ann Neurol 48 2 2000 148 155 (Pubitemid 30617032)
111. R.H. Swerdlow Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies J Neurosci Res 85 15 2007 3416 3428 (Pubitemid 350058530)
112. S.A. Schneider, G. Zorzi, and N. Nardocci Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population Curr Treat Options Neurol 15 5 2013 652 667
113. E. Lee, J.E. Eom, H.L. Kim, K.H. Baek, K.Y. Jun, and H.J. Kim et al. Effect of conjugated linoleic acid, mu-calpain inhibitor, on pathogenesis of Alzheimer's disease Biochim Biophys Acta-Mol Cell Biol Lipids 1831 4 2013 709 718
114. C.A. Briggs, C. Schneider, J.C. Richardson, and G.E. Stutzmann Beta amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice Neurobiol Aging 34 6 2013 1632 1643
115. S. Tan, Y. Sagara, Y. Liu, P. Maher, and D. Schubert The regulation of reactive oxygen species production during programmed cell death J Cell Biol 141 6 1998 1423 1432 (Pubitemid 28289917)
116. V.G. Grivennikova, and A.D. Vinogradov Generation of superoxide by the mitochondrial complex I Biochim Biophys Acta 1757 5-6 2006 553 561 (Pubitemid 43993849)
117. M.A. Ansari, and S.W. Scheff Oxidative stress in the progression of Alzheimer disease in the frontal cortex J Neuropathol Exp Neurol 69 2 2010 155 167
118. C.L. Quinlan, I.V. Perevoshchikova, M. Hey-Mogensen, A.L. Orr, and M.D. Brand Sites of reactive oxygen species generation by mitochondria oxidizing different substrates Redox Biol 1 1 2013 304 312
119. S.D. Edland, J.M. Silverman, E.R. Peskind, D. Tsuang, E. Wijsman, and J.C. Morris Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance Neurology 47 1 1996 254 256 (Pubitemid 26243893)
120. L. Mosconi, V. Berti, R.H. Swerdlow, A. Pupi, R. Duara, and M. de Leon Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes Hum Genomics 4 3 2010 170 193
121. R. Duara, R.F. Lopez-Alberola, W.W. Barker, D.A. Loewenstein, M. Zatinsky, and C.E. Eisdorfer et al. A comparison of familial and sporadic Alzheimer's disease Neurology 43 7 1993 1377 1384 (Pubitemid 23213814)
122. R.E. Giles, H. Blanc, H.M. Cann, and D.C. Wallace Maternal inheritance of human mitochondrial DNA Proc Natl Acad Sci USA 77 11 1980 6715 6719 (Pubitemid 11163470)
123. M.E. Gotz, K. Double, M. Gerlach, M.B.H. Youdim, and P. Riederer The relevance of iron in the pathogenesis of Parkinson's disease Ann N Y Acad Sci 1012 2004 193 208 (Pubitemid 38455479)
124. C.S. Atwood, X.D. Huang, R.D. Moir, R.E. Tanzi, and A.I. Bush Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease Met Ions Biol Syst 36 1999 309 364
125. X. Huang, R.D. Moir, R.E. Tanzi, A.I. Bush, and J.T. Rogers Redox-active metals, oxidative stress, and Alzheimer's disease pathology Ann N Y Acad Sci 1012 2004 153 163 (Pubitemid 38453522)
126. L. Goodman Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis J Nerv Ment Dis 118 2 1953 97 130
127. M.A. Smith, P.L. Harris, L.M. Sayre, and G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci USA 94 18 1997 9866 9868 (Pubitemid 27408156)
128. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P.L.R. Harris, and S.L. Siedlak et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress J Neurochem 70 5 1998 2212 2215 (Pubitemid 28207848)
129. A. Yamamoto, R.W. Shin, K. Hasegawa, H. Naiki, H. Sato, and F. Yoshimasu et al. Iron(III) induces aggregation of hyperphosphorylated tau and its reduction to iron(II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease J Neurochem 82 5 2002 1137 1147 (Pubitemid 34966626)
130. C. Behl, J.B. Davis, R. Lesley, and D. Schubert Hydrogen-peroxide mediates amyloid-beta protein toxicity Cell 77 6 1994 817 827 (Pubitemid 24187680)
131. X.D. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, and R.C. Scarpa et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction Biochemistry 38 24 1999 7609 7616 (Pubitemid 29289332)
132. M.E. Harris, K. Hensley, D.A. Butterfield, R.A. Leedle, and J.M. Carney Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons Exp Neurol 131 2 1995 193 202
133. L. Wang, G. Xi, R.F. Keep, and Y. Hua Iron enhances the neurotoxicity of amyloid beta Transl Stroke Res 3 1 2012 107 113
134. C. Mueller, M. Schrag, A. Crofton, J. Stolte, M.U. Muckenthaler, and S. Magaki et al. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment J Alzheimers Dis 29 2 2012 341 350
135. Y. Arai, A. Suzuki, M. Mizuguchi, and S. Takashima Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains Brain Dev 19 4 1997 290 294 (Pubitemid 27236856)
136. K. Furuyama, K. Kaneko, and P.D. Vargas Heme as a magnificent molecule with multiple missions: Heme determines its own fate and governs cellular homeostasis Tohoku J Exp Med 213 1 2007 1 16 (Pubitemid 47516896)
137. M.P. Horowitz, and J.T. Greenamyre Mitochondrial iron metabolism and its role in neurodegeneration J Alzheimers Dis 20 2010 S551 S568
138. A. Barrientos, J. Casademont, F. Cardellach, X. Estivill, A. Urbano-Marquez, and V. Nunes Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging Brain Res Mol Brain Res 52 2 1997 284 289 (Pubitemid 28043472)
139. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, M.F. Beal, and D.C. Wallace Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age Nat Genet 2 4 1992 324 329
140. R.H. Swerdlow, and S.J. Kish Mitochondria in Alzheimer's disease Int Rev Neurobiol 53 2002 341 385
141. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 6865 2001 799 806 (Pubitemid 34000783)
142. S. Jitrapakdee, A. Wutthisathapornchai, J.C. Wallace, and M.J. MacDonald Regulation of insulin secretion: role of mitochondrial signalling Diabetologia 53 6 2010 1019 1032
143. P. Maechler Mitochondrial function and insulin secretion Mol Cell Endocrinol 379 1-2 2013 12 18
144. B.S. Jhun, H. Lee, Z.G. Jin, and Y. Yoon Glucose stimulation induces dynamic change of mitochondrial morphology to promote insulin secretion in the insulinoma cell line INS-1E PLoS ONE 8 4 2013 e60810
145. R.G. Kibbey, R.L. Pongratz, A.J. Romanelli, C.B. Wollheim, G.W. Cline, and G.I. Shulman Mitochondrial GTP regulates glucose-stimulated insulin secretion Cell Metab 5 4 2007 253 264 (Pubitemid 46477853)
146. G.F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr Rev 23 2 2002 201 229 (Pubitemid 34299024)
147. S.D. Martin, and S.L. McGee The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes Biochim Biophys Acta 2013 10.1016/j.bbagen.2013.09.019 pii: S0304-4165(13)00400-5
148. Y. Sako, and V.E. Grill A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin-secretion and B-cell oxidation through a process likely coupled to fatty-acid oxidation Endocrinology 127 4 1990 1580 1589 (Pubitemid 20315212)
149. E.L. Opie The relation Oe diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands Oe Langerhans J Exp Med 5 5 1901 527 540
150. P. Westermark, C. Wernstedt, E. Wilander, and K. Sletten A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas Biochem Biophys Res Commun 140 3 1986 827 831 (Pubitemid 17207764)
151. J.W. Hoppener, B. Ahren, and C.J. Lips Islet amyloid and type 2 diabetes mellitus N Engl J Med 343 6 2000 411 419 (Pubitemid 30626125)
152. P. Westermark Amyloid and polypeptide hormones - what is their interrelationship Amyloid 1 1 1994 47 60
153. X.L. Li, T. Chen, Y.S. Wong, G. Xu, R.R. Fan, and H.L. Zhao et al. Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: an effect attenuated by phycocyanin Int J Biochem Cell Biol 43 4 2011 525 534
154. H. Xiong, C. Zheng, J. Wang, J. Song, G. Zhao, and H. Shen et al. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice J Alzheimers Dis 37 3 2013 623 635
155. C. Holscher Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases J Endocrinol 2013 10.1530/JOE-13-0221 [Epub ahead of print]
156. R. Fan, X. Li, X. Gu, J.C. Chan, and G. Xu Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis Diabetes Obes Metab 12 9 2010 815 824
157. M. Kan, G. Guo, B. Singh, V. Singh, and D.W. Zochodne Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy J Neuropathol Exp Neurol 71 6 2012 494 510
158. J.A. Simcox, and D.A. McClain Iron and diabetes risk Cell Metabolism 17 March 2013 329 341
159. M.H. Mendler, B. Turlin, R. Moirand, A.M. Jouanolle, T. Sapey, and D. Guyader et al. Insulin resistance-associated hepatic iron overload Gastroenterology 117 5 1999 1155 1163 (Pubitemid 29512675)
160. M.C. Thomas, R.J. MacIsaac, C. Tsalamandris, and G. Jerums Elevated iron indices in patients with diabetes Diabet Med 21 7 2004 798 802 (Pubitemid 38916230)
161. E.S. Ford, and M.E. Cogswell Diabetes and serum ferritin concentration among US adults Diabetes Care 22 12 1999 1978 1983 (Pubitemid 30433975)
162. A. Aregbesola, S. Voutilainen, J.K. Virtanen, J. Mursu, and T.P. Tuomainen Body iron stores and the risk of type 2 diabetes in middle-aged men Eur J Endocrinol 169 2 2013 247 253
163. C.L. Cheung, T.T. Cheung, K.S. Lam, and B.M. Cheung High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults Clin Nutr 32 6 2013 1055 1060
164. Y. Rong, W. Bao, S. Rong, M. Fang, D. Wang, and P. Yao et al. Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis Am J Epidemiol 176 6 2012 461 472
165. R. Jiang, J. Ma, A. Ascherio, M.J. Stampfer, W.C. Willett, and F.B. Hu Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study Am J Clin Nutr 79 1 2004 70 75 (Pubitemid 41132064)
166. J.M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Iron stores, blood donation, and insulin sensitivity and secretion Clin Chem 51 7 2005 1201 1205 (Pubitemid 43079398)
167. A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, and R. Freeman et al. Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 4 2005 956 962 (Pubitemid 40434506)
168. S.K. Chowdhury, D.R. Smith, and P. Fernyhough The role of aberrant mitochondrial bioenergetics in diabetic neuropathy Neurobiol Dis 51 2013 56 65
169. S.K. Chowdhury, R.T. Dobrowsky, and P. Fernyhough Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes Mitochondrion 11 6 2011 845 854
170. A. Saleh, S.K.R. Chowdhury, D.R. Smith, S. Balakrishnan, L. Tessler, and C. Martens et al. Ciliary neurotrophic factor activates NF-kappa B to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents Neuropharmacology 65 2013 65 73
171. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2 2001 129 146 (Pubitemid 32156196)
172. P.J. Beisswenger, S.K. Howell, G.B. Russell, M.E. Miller, S.S. Rich, and M. Mauer Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products Diabetes Care 36 10 2013 3234 3239
173. A. Bierhaus, T. Fleming, S. Stoyanov, A. Leffler, A. Babes, and C. Neacsu et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy Nat Med 18 6 2012 926 933
174. Y. Deng, Y. Zhang, Y. Li, S. Xiao, D. Song, and H. Qing et al. Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains J Neural Transm 119 4 2012 435 441
175. C.G. Jolivalt, R. Hurford, C.A. Lee, W. Dumaop, E. Rockenstein, and E. Masliah Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice Exp Neurol 223 2 2010 422 431
176. A. Currais, M. Prior, D. Lo, C. Jolivalt, D. Schubert, and P. Maher Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice Aging Cell 11 6 2012 1017 1026
177. C. Belin, and M.T. Gatt Pain and dementia Psychol Neuropsychiatr Vieil 4 4 2006 247 254 (Pubitemid 46051896)
178. C.G. Jolivalt, N.A. Calcutt, and E. Masliah Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease Neuroscience 202 2012 405 412
179. A.A. Sima, and Z.G. Li Diabetes and Alzheimer's disease - is there a connection? Rev Diabet Stud 3 4 2006 161 168
180. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, and T. Guido et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 6740 1999 173 177 (Pubitemid 29327547)
181. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, and S.D. Schmidt et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 6815 2000 979 982 (Pubitemid 32101644)
182. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, and J. Hardy et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 6815 2000 982 985 (Pubitemid 32101645)
183. P.S. Aisen, and B. Vellas Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed? J Nutr Health Aging 17 1 2013 49 50
184. J.O. Rinne, D.J. Brooks, M.N. Rossor, N.C. Fox, R. Bullock, and W.E. Klunk et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Lancet Neurol 9 4 2010 363 372
185. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto Alzheimer's disease: clinical trials and drug development Lancet Neurol 9 7 2010 702 716
186. N. Joseph-Mathurin, O. Dorieux, S.G. Trouche, A. Boutajangout, A. Kraska, and P. Fontes et al. Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds Neurobiol Aging 34 11 2013 2613 2622
187. R.H. Swerdlow Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases Curr Pharm Des 17 31 2011 3356 3373
188. R.H. Swerdlow Bioenergetic medicine Br J Pharmacol 2013 10.1111/bph.12394
189. S. Yoneda, S. Uno, H. Iwahashi, Y. Fujita, A. Yoshikawa, and J. Kozawa et al. Predominance of beta-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes J Clin Endocrinol Metab 98 5 2013 2053 2061
190. C.J. Greenbaum, B. Buckingham, H.P. Chase, and J. Krischer Diabetes prevention trial TDSG: metabolic tests to determine risk for type 1 diabetes in clinical trials Diabetes Metab Res Rev 27 6 2011 584 589
191. M. Sysi-Aho, A. Ermolov, P.V. Gopalacharyulu, A. Tripathi, T. Seppanen-Laakso, and J. Maukonen et al. Metabolic regulation in progression to autoimmune diabetes PLoS Comput Biol 7 10 2011 e1002257
192. E.B. Tsai, N.A. Sherry, J.P. Palmer, and K.C. Herold The rise and fall of insulin secretion in type 1 diabetes mellitus Diabetologia 49 2 2006 261 270 (Pubitemid 43185394)
193. H. Beck-Nielsen, and L.C. Groop Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus J Clin Invest 94 5 1994 1714 1721
194. M. Xu, W. Wang, J.R. Frontera, M.C. Neely, J. Lu, and D. Aires et al. Ncb5or deficiency increases fatty acid catabolism and oxidative stress J Biol Chem 286 13 2011 11141 11154
195. L. Aiyar, C. Shuman, R. Hayeems, A. Dupuis, S. Pu, and S. Wodak et al. Risk estimates for complex disorders: comparing personal genome testing and family history Genet Med 2013 10.1038/gim.2013.115